RMI exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The stock is trading at a massive premium to its growth-based intrinsic value of $0.84, with an unjustifiable P/E ratio of 126.42 and 0% profit margins. Most alarmingly, the dividend payout ratio of 940.33% suggests the current yield is unsustainable and likely funded by capital erosion or leverage rather than earnings. Despite recent positive price action, the underlying deterministic metrics signal a high-risk value trap.